An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A

NCT01328444 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

349

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: GSK 573719 +GW642444 125/25
DRUG: GSK573719 + GW642444 62.5/25
DRUG: GSK 573719 125
DRUG: GSK 573719 62.5
DRUG: GW642444 25
DRUG: Plb

Sponsor

GlaxoSmithKline